The contemporary role of sinus surgery in managing cystic fibrosis

Despite prominent advances in disease modifying therapies, ESS remains a treatment option to manage refractory sinonasal symptoms and CRS in people with CF who do not respond to medical therapy. The decision to pursue ESS remains individualized and should involve a multidisciplinary discussion between clinicians to optimize patient selection, surgical goals, and perioperative medical management.